Roche wins breakthrough designation for Tau biomarker test for Alzheimer’s
Roche’s Elecsys pTau217 plasma biomarker test was developed in partnership with Eli Lilly and can be used to identify the amyloid pathology of Alzheimer’s disease.
12 April 2024
12 April 2024
Roche’s Elecsys pTau217 plasma biomarker test was developed in partnership with Eli Lilly and can be used to identify the amyloid pathology of Alzheimer’s disease.
The Fujifilm site expansion is set to add 680 jobs to the site and expand Fujifilm’s contract research business and production capacity across North America.
Steris' HuFriedyGroup offers a range of instruments, infection prevention products, and management systems.
The clinical trial of the Lumerah system is set to begin in April 2024 in Norfolk, Virginia, under FDA IDE.
Simpson Intervention is now eligible for prioritised review along with enhanced FDA feedback.
The Patholytix Foresight decision support tool is intended to help accelerate primary evaluation and peer review processes.
The study will assess the economic and healthcare outcome benefits of Acarix's AI-powered CADScor System compared to traditional stress test.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.